C8ORF44 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.258400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.410800E-01
Normal-vs-Stage2
3.512200E-01
Normal-vs-Stage3
3.387000E-01
Normal-vs-Stage4
5.906400E-01
Stage1-vs-Stage2
4.544600E-01
Stage1-vs-Stage3
5.343800E-03
Stage1-vs-Stage4
3.982200E-01
Stage2-vs-Stage3
1.204960E-01
Stage2-vs-Stage4
9.776800E-01
Stage3-vs-Stage4
4.436400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.453200E-01
Normal-vs-AfricanAmerican
6.182200E-01
Normal-vs-Asian
4.475000E-01
Caucasian-vs-AfricanAmerican
7.320200E-01
Caucasian-vs-Asian
7.958800E-01
AfricanAmerican-vs-Asian
9.113000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.179400E-01
Normal-vs-Female
4.638800E-01
Male-vs-Female
9.296200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.533000E-01
Normal-vs-Age(41-60Yrs)
4.973800E-01
Normal-vs-Age(61-80Yrs)
4.486400E-01
Normal-vs-Age(81-100Yrs)
5.507000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.473800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.985600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.380100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.955000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.248400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.836800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.742800E-01
Normal-vs-Daily Drinker
6.653800E-01
Normal-vs-Weekly Drinker
2.664200E-01
Normal-vs-Occasional Drinker
7.555800E-01
Normal-vs-Social Drinker
8.839000E-01
Non Drinker-vs-Daily Drinker
5.314000E-01
Non Drinker-vs-Weekly Drinker
3.256800E-01
Non Drinker-vs-Occasional Drinker
4.906200E-01
Non Drinker-vs-Social Drinker
1.071000E-01
Daily Drinker-vs-Weekly Drinker
2.363800E-01
Daily Drinker-vs-Occasional Drinker
8.802000E-01
Daily Drinker-vs-Social Drinker
2.728400E-01
Weekly Drinker-vs-Occasional Drinker
2.351400E-01
Weekly Drinker-vs-Social Drinker
4.553900E-02
Occasional Drinker-vs-Social Drinker
3.940400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.480170E-01
Normal-vs-Grade 2
1.379770E-02
Normal-vs-Grade 3
2.707900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.688800E-01
Grade 1-vs-Grade 3
9.890400E-01
Grade 1-vs-Grade 4
1.480170E-01
Grade 2-vs-Grade 3
1.125440E-01
Grade 2-vs-Grade 4
1.379770E-02
Grade 3-vs-Grade 4
2.707900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.770600E-01
Normal-vs-NonDiabetic
5.500200E-01
Diabetic-vs-NonDiabetic
3.885000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.549200E-01
Normal-vs-NoPancreatitis
4.097000E-01
Pancreatitis-vs-NoPancreatitis
1.434360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.079000E-01
Normal-vs-N1
3.090200E-01
N0-vs-N1
1.532760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.664400E-01
Normal-vs-TP53-NonMutant
5.514000E-01
TP53-Mutant-vs-TP53-NonMutant
6.549600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
